Skip to content
Portfolio
About us
Contact us
News & Press
Investment
LightOx raises £1.5m to develop oral cancer preventative treatment
June 13, 2024
Investment
Mesenbio raises £1.4M to develop therapeutic pipeline
January 9, 2024
Investment
Bastion Therapeutics secures financing to develop advanced Treg therapeutics
September 12, 2023
Exit
Molecular Devices adds proprietary patient-derived organoid technology with acquisition of Cellesce
December 6, 2022
Investment
Abselion (at the time HexagonFab) secures $2.6m seed funding to launch the Bolt
April 20, 2021